Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Duangjai Todsaporn"'
Autor:
Duangjai Todsaporn, Alexander Zubenko, Victor Kartsev, Thitinan Aiebchun, Panupong Mahalapbutr, Anthi Petrou, Athina Geronikaki, Liudmila Divaeva, Victoria Chekrisheva, Ilkay Yildiz, Kiattawee Choowongkomon, Thanyada Rungrotmongkol
Publikováno v:
Molecules, Vol 28, Iss 7, p 3014 (2023)
Targeting L858R/T790M and L858R/T790M/C797S mutant EGFR is a critical challenge in developing EGFR tyrosine kinase inhibitors to overcome drug resistance in non-small cell lung cancer (NSCLC). The discovery of next-generation EGFR tyrosine kinase inh
Externí odkaz:
https://doaj.org/article/551a531ba4fd47eebd77d51c671c2851
Autor:
Duangjai Todsaporn, Panupong Mahalapbutr, Rungtiva P. Poo-arporn, Kiattawee Choowongkomon, Thanyada Rungrotmongkol
Publikováno v:
Computers in biology and medicine. 147
Mutations in the tyrosine kinase domain of epidermal growth factor receptor (EGFR), including L858R/T790M double and L858R/T790M/C797S triple mutations, are major causes of acquired resistance towards EGFR targeted drugs. In this work, a combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a95c9ba9b7824b9ad1c2b1d327a62c
https://pubmed.ncbi.nlm.nih.gov/35803080
https://pubmed.ncbi.nlm.nih.gov/35803080
Autor:
Panupong Mahalapbutr, Ronnakorn Leechaisit, Anusit Thongnum, Duangjai Todsaporn, Veda Prachayasittikul, Thanyada Rungrotmongkol, Supaluk Prachayasittikul, Somsak Ruchirawat, Virapong Prachayasittikul, Ratchanok Pingaew
Publikováno v:
ACS omega. 7(21)
Epidermal growth factor receptor (EGFR) has been recognized as one of the attractive targets for anticancer drug development. Herein, a set of anilino-1,4-naphthoquinone derivatives (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::628dbb2abbc163103c5ed28be7211545
https://pubmed.ncbi.nlm.nih.gov/35664590
https://pubmed.ncbi.nlm.nih.gov/35664590